Cerevel Therapeutics Holdings, Inc.
CERE · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$132 | -$133 | $8 | -$10 |
| Dep. & Amort. | $2 | $2 | $1 | $1 |
| Deferred Tax | $0 | -$28 | -$108 | -$94 |
| Stock-Based Comp. | $21 | $25 | $17 | $15 |
| Change in WC | -$5 | $9 | $17 | $1 |
| Other Non-Cash | -$5 | $28 | -$8 | $10 |
| Operating Cash Flow | -$120 | -$97 | -$73 | -$77 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | -$0 | -$0 |
| Inv. Purchases | -$123 | -$317 | -$213 | -$147 |
| Inv. Sales/Matur. | $142 | $168 | $265 | $211 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | $19 | -$150 | $51 | $62 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$0 | $508 | $1 | $6 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4 | $508 | $1 | $38 |
| Financing Cash Flow | $4 | $508 | $1 | $38 |
| Forex Effect | $0 | $53 | $28 | -$32 |
| Net Chg. in Cash | -$96 | $314 | -$20 | $22 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $418 | $677 | $178 | $156 |
| End Cash | $322 | $991 | $158 | $178 |
| Free Cash Flow | -$120 | -$98 | -$73 | -$79 |